Literature DB >> 16632301

The return of natalizumab: weighing benefit against risk.

Douglas Goodin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16632301     DOI: 10.1016/S1474-4422(06)70419-7

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  1 in total

1.  The evolving role of the multiple sclerosis nurse: an international perspective.

Authors:  Therese Burke; Sara Dishon; Lynn McEwan; Jennifer Smrtka
Journal:  Int J MS Care       Date:  2011
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.